Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID06686121

IMProving Mobility After revasCularizaTion in Peripheral Artery Disease: The IMPACT PAD Trial

Led by Northwestern University · Updated on 2025-08-26

386

Participants Needed

7

Research Sites

26 weeks

Total Duration

On this page

Sponsors

N

Northwestern University

Lead Sponsor

R

Rancho Research Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating ways to improve walking ability in people with peripheral artery disease (PAD) who have undergone lower extremity revascularization for disabling symptoms. The study evaluates whether adding home-based exercise or drinking nitrate-rich beetroot juice can help improve walking distance more than revascularization alone. This randomized clinical trial has a two-by-two design and aims to test these interventions in 386 patients within three months after successful revascularization. Participants will be assigned to one of four groups: home-based exercise plus nitrate-rich beetroot juice, home-based exercise plus placebo beetroot juice, attention control plus nitrate-rich beetroot juice, or attention control plus placebo beetroot juice. The home-based exercise involves walking at home with coaching support over six months, starting with 2-4 weekly meetings followed by weekly phone calls. Beetroot juice or placebo shots are taken twice daily for six months. The attention control group attends weekly educational sessions on health topics during the same period. During the study, patients will undergo baseline and follow-up assessments including a six-minute walk test to measure walking distance. Additional questionnaires will evaluate walking impairment and mobility. Researchers will monitor blood flow in the treated vessels and measure nitric oxide levels in the blood. The main outcomes are measured at six and twelve months after starting the interventions. Safety, adherence, and quality of life will be tracked throughout the study, which plans to follow participants up to eight years after enrollment.

CONDITIONS

Brief Title

Improving Mobility After Revascularization in Peripheral Artery Disease

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Successful lower extremity revascularization for disabling PAD performed at least 30 days before baseline testing and between 30 and 100 days before randomization
  • Age 18 years or older
  • Able and willing to adhere to study interventions and complete follow-up testing
  • Willing to drink study beverages as assigned
  • Able to accept randomization into either home-based exercise or attention control group
Not Eligible

You will not qualify if you...

  • History of leg amputation beyond toe or partial foot amputation
  • Active gangrene or limb threatening ischemia
  • Currently exercising at level consistent with study exercise intervention
  • Unstable angina
  • Taking sildenafil, tadalafil, or similar drugs
  • Currently consuming beetroot juice, oral nitrate, nitrite, or beetroot supplements and unwilling to stop
  • History of kidney stones requiring low oxalate intake
  • Baseline blood pressure less than 100/45
  • Wheelchair confinement or requiring a walker to walk
  • Walking limitation caused by condition other than PAD
  • Current foot ulcer
  • Planned major surgery or coronary/lower extremity revascularization in next 12 months
  • Major illness with life expectancy under six months
  • Allergy to beetroot juice
  • Consuming one cup or more of beets daily and unwilling to reduce intake
  • Participation in another clinical trial within past three months
  • Visual impairment limiting walking
  • Unable to communicate in English or Spanish at sites without Spanish-speaking staff
  • Using bactericidal mouthwash and unwilling to discontinue
  • Planning to start supervised treadmill exercise in next 12 months
  • Heart attack or stroke within past three months
  • Investigator discretion for safety or fit concerns

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 6 months

Participants receive lower extremity revascularization followed by randomization to one of four groups combining home-based exercise or attention control with nitrate-rich beetroot juice or placebo. Home-based exercise includes walking at home with coaching calls and in-person meetings. Participants drink a shot of beetroot juice or placebo twice daily for six months.

2 to 4 weekly in-person meetings with a coach for the first 4 weeks, then weekly telephone coaching calls for the remainder of 6 months

Follow-up

Duration - Up to 6 months after treatment ends (12 months total from baseline)

Participants are monitored for walking performance and vascular health up to 12 months after baseline to assess the durability of treatment effects.

Visits at 6-month and 12-month follow-ups

Trial Site Locations

Total: 7 locations

1

University of Arizona

Tucson, Arizona, United States, 85724

Not Yet Recruiting

2

Rancho Research Institute

Downey, California, United States, 90242

Actively Recruiting

3

Emory University School of Medicine

Atlanta, Georgia, United States, 30307

Not Yet Recruiting

4

Northwestern University Feinberg School of Medicine

Chicago, Illinois, United States, 60611

Actively Recruiting

5

University of Chicago

Chicago, Illinois, United States, 60637

Actively Recruiting

6

Dartmouth Hitchcock Medical Center

Lebanon, New Hampshire, United States, 03766

Not Yet Recruiting

7

University of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15213

Not Yet Recruiting

Loading map...

Research Team

M

Mary M McDermott, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

FACTORIAL

Primary Purpose

TREATMENT

Number of Arms

4

Similar Trials

A Post Market Clinical Study to Evaluate the Safety and Effi...

Peripheral Artery Disease

Actively Recruiting

1 location

All Comers Post Market Clinical Follow-up to Continue Survei...

Peripheral Artery Disease

Actively Recruiting

7 locations

Evaluation of Patients Who Underwent Revascularization of Ao...

Aorta Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here